BioSwift Talent

In March, I injured my arm and had to stop most of my favourite activities. I am still recovering, but this setback allowed me to discover so many new things I now enjoy even more! Now, I absolutely love going out into the wilderness on the weekend with my girlfriend & exploring places we would have never been if I had not injured myself and had stuck to my old routine. When I thought about it, it was a solid reminder that setbacks can often present opportunities or even put you on a better path than you were before. If you have been laid off, or your new job isn't panning out as expected. Then just remember that this change you are experiencing, although it may be painful, sometimes it is for the best!

Schizophrenia-related hallucinations linked to disrupted motor-sensory signals 🧠🔗👁️ New research reveals that the brain's failure to self-monitor motor signals plays a key role in schizophrenia-related hallucinations, offering fresh insights into the mechanisms behind these perceptual distortions. It's wild how the brain's own signals can cause such vivid, unreal experiences. Link in the comments for the full story. 🌐

Editas cashes in on portion of Vertex gene editing licensing agreement for $57M 💉💰 Editas Medicine has sold a portion of its licensing rights from Vertex Pharmaceuticals for $57 million upfront to DRI Healthcare. This deal includes future annual license fees, ranging from $5 million to $40 million per year, and part of a $50 million contingent payment from Vertex. Editas retains this year's fee and a payment tied to Vertex's sales milestones. The funds will support Editas' gene therapy development, including ongoing studies for sickle cell disease and beta thalassemia. CEO Gilmore O’Neill highlighted this as non-dilutive capital to advance their pipeline. Smart move by Editas—selling part of their licensing rights for quick cash while keeping their focus on developing future gene therapies. Link in the comments for the full story. 🌐

In a tough job market, outstanding skills will take you far... But your network will take you further! The things successful candidates do really leaves no question why they are the ones securing the jobs. Successful candidates I have spoken to recently: Apply for *relevant* jobs on multiple platforms Contact recruiters directly for work Ask around their network if anyone knows anyone who is hiring for their skillset. In a tough market, it is about staying ahead of the curve. Applying to jobs online is great, but you will always be competing with 100's of other candidates. By using your network, you can find jobs before they are published, therefore circumventing the competition entirely 💯 Want to secure a job faster? Reach out to your network to find the jobs before they are published 🚀

Cancer Research UK backs study to develop preventive ovarian cancer vaccine 🎗️🔬 Cancer Research UK scientists are developing a vaccine to prevent ovarian cancer by targeting proteins on early cancer cells. If successful, clinical trials will follow, offering a preventive option, especially for women with BRCA1/2 gene mutations, who currently face surgery that causes infertility and early menopause. It's incredible to think that a vaccine like this could one day save so many women from both cancer and the difficult choices they currently have to make. Link in the comments for the full story. 🌐

Lundbeck taps Charles River for AI-enabled neuro drug discovery 🧠🔬 Lundbeck has partnered with Charles River Laboratories to use the AI platform Logica in neuroscience drug discovery. Developed with Valo Health, Logica combines machine learning, tissue biology, and patient data to streamline drug development. Lundbeck aims to apply this technology to central nervous system disorders, potentially improving outcomes and creating targeted therapies, as noted by Dr. Tarek Samad, head of global research. It's exciting to see how Lundbeck is harnessing AI to push the boundaries of neuroscience research, this could really lead to breakthroughs in treating brain disorders! Link in the comments for the full story. 🌐

New pathway linking neuron selectivity to cognitive disorders uncovered 🧠🔗 Johns Hopkins researchers have found that calcium permeable (CP)-AMPA receptors reduce the selectivity of certain neurons, making them less responsive to specific external cues. This discovery, published in Nature, may help in understanding conditions like schizophrenia, epilepsy, and autism. The study, led by Ingie Hong, Ph.D., and Richard Huganir, Ph.D., shows that CP-AMPA receptors inhibit parvalbumin (PV) neurons, affecting how the brain processes information. It’s fascinating how understanding a single receptor like CP-AMPA could potentially unlock new ways to approach complex brain disorders like schizophrenia and autism! Link in the comments for the full story. 🌐

CAMP4, BioMarin ink research deal for genetic disease targets 🔬🤝🧬 CAMP4 Therapeutics has partnered with BioMarin to work on developing treatments for genetic diseases. BioMarin gains the rights to select two targets from CAMP4’s RNA platform, which is designed to address diseases by optimizing protein expression. The collaboration focuses on using regulatory RNAs to develop innovative therapies. BioMarin will provide an upfront payment, with potential milestones and royalties included in the deal. It's exciting to see BioMarin teaming up with CAMP4 Therapeutics, this partnership could open up some really promising avenues for tackling genetic diseases with RNA-based therapies! Link in the comments for the full story. 🌐

CheekAge can accurately predict the risk of mortality, study shows 🔬👵➡️📅 Not everyone ages at the same rate, with genetics, lifestyle, and behavioral factors like stress, poor sleep, and smoking influencing the pace of aging. These factors leave epigenetic marks on our genome, allowing scientists to measure molecular aging through epigenetic clocks. Over the past decade, clocks based on DNA methylation in blood cells were developed, but collecting these samples can be burdensome. Recently, scientists introduced CheekAge, a second-generation epigenetic clock using easily collected cheek cells. A new study shows CheekAge can accurately predict mortality risk, even when using epigenetic data from other tissues. It's fascinating how something as simple as a cheek swab can offer such deep insights into our health and longevity, makes you think about how much our everyday choices really impact us! Link in the comments for the full story. 🌐

A med tech Sales VP I spoke to was the top performer in his company 💰 Until management made her sell the underperforming products only. What happened? Being an extremely persistent and motivated person, she spent months trying to establish a market for these products. But there simply wasn't a product market fit. So she came to me for help in finding her next role, and her company is about to lose their top performer and multi-millions of revenue... 🤦♂️ Even with the best salespeople on the planet, product-market fit is still a thing... Let your top performers keep doing what they do best & they will love you for it. Change what they are doing without consulting them and suffer the consequences! ⚡